Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday

  • Goldman Sachs raised Wells Fargo & Company WFC price target from $46 to $48. Goldman Sachs analyst Richard Ramsden upgraded the stock from Neutral to Buy. Wells Fargo shares rose 1.1% to $40.68 in pre-market trading.
  • Baird cut the price target on Intercept Pharmaceuticals, Inc. ICPT from $52 to $35. Baird analyst Brian Skorney maintained an Outperform rating on the stock. Intercept Pharmaceuticals shares fell 15% to close at $13.95 on Friday.
  • Mizuho cut Sempra SRE price target from $173 to $161. Mizuho analyst Anthony Crowdell maintained a Buy rating on the stock. Sempra shares fell 1% to close at $149.94 on Friday.
  • B of A Securities lowered Livent Corporation LTHM price target from $31 to $27. B of A Securities analyst Matthew DeYoe downgraded the stock from Neutral to Underperform. Livent fell 4% to $29.42 in pre-market trading.
  • SVB Leerink cut Replimune Group, Inc. REPL price target from $37 to $30. SVB Leerink analyst Jonathan Chang maintained an Outperform rating on the stock. Replimune shares rose 3.9% to close at $17.27 on Friday.
  • HC Wainwright & Co. boosted Axcella Health Inc. AXLA price target from $8 to $10. HC Wainwright & Co. analyst Ed Arce maintained the stock with a Buy. Axcella Health shares fell 11.4% to close at $1.71 on Friday.

Check out this: US Stock Futures Mixed After Recording Quarterly Losses; Tesla In Focus

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading IdeasPrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!